BAYNON INTERNATIONAL CORP
10QSB, EX-27.1, 2000-08-11
BLANK CHECKS
Previous: BAYNON INTERNATIONAL CORP, 10QSB, 2000-08-11
Next: NOVA PHARMACEUTICAL INC, NT 10-Q, 2000-08-11



<TABLE> <S> <C>

<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                 6-MOS
<FISCAL-YEAR-END>                           DEC-31-2000
<PERIOD-END>                                JUN-30-2000
<CASH>                                               44
<SECURITIES>                                          0
<RECEIVABLES>                                         0
<ALLOWANCES>                                          0
<INVENTORY>                                           0
<CURRENT-ASSETS>                                     44
<PP&E>                                                0
<DEPRECIATION>                                        0
<TOTAL-ASSETS>                                       44
<CURRENT-LIABILITIES>                                 3
<BONDS>                                               0
                                 0
                                           0
<COMMON>                                             10
<OTHER-SE>                                           41
<TOTAL-LIABILITY-AND-EQUITY>                         44
<SALES>                                               0
<TOTAL-REVENUES>                                      0
<CGS>                                                 0
<TOTAL-COSTS>                                         7
<OTHER-EXPENSES>                                      0
<LOSS-PROVISION>                                      0
<INTEREST-EXPENSE>                                  (1)
<INCOME-PRETAX>                                     (6)
<INCOME-TAX>                                          0
<INCOME-CONTINUING>                                   0
<DISCONTINUED>                                        0
<EXTRAORDINARY>                                       0
<CHANGES>                                             0
<NET-INCOME>                                        (6)
<EPS-BASIC>                                           0
<EPS-DILUTED>                                         0


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission